- Filed
- Nov 13, 2023 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · Nov 10, 2023 | 421.04M sh |
| Capex | Q1 2024 · Sep 30, 2023 | $0 |
| Capex | Q1 2024 · Sep 30, 2022 | $2.57K |
| Stockholders Equity | Q1 2024 · Sep 30, 2023 | −$6.9M |
| Stockholders Equity | Q1 2024 · Jun 30, 2023 | −$6.62M |
| Stockholders Equity restated | Q1 2024 · Sep 30, 2022 | −$5.51M |
| Stockholders Equity restated | Q1 2024 · Jun 30, 2022 | −$2.96M |
| Current Liabilities | Q1 2024 · Sep 30, 2023 | $7.13M |
| Current Liabilities | Q1 2024 · Jun 30, 2023 | $6.75M |
| Total Liabilities | Q1 2024 · Sep 30, 2023 | $7.15M |
| Total Liabilities | Q1 2024 · Jun 30, 2023 | $6.79M |
| Current Assets | Q1 2024 · Sep 30, 2023 | $168.21K |
| Current Assets | Q1 2024 · Jun 30, 2023 | $66.15K |
| Total Assets | Q1 2024 · Sep 30, 2023 | $256.65K |
| Total Assets | Q1 2024 · Jun 30, 2023 | $167.12K |
| Operating Cash Flow | Q1 2024 · Sep 30, 2022 | −$565.34K |
| Rd Expense | Q1 2024 · Sep 30, 2022 | $0 |
| Net Income | Q1 2024 · Sep 30, 2022 | −$4.82M |
| Operating Income | Q1 2024 · Sep 30, 2022 | −$735.99K |